Centogene NV (Centogene NV) Change In Payables And Accrued Expense : $-7.10 Mil (TTM As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Centogene NV Change In Payables And Accrued Expense?

Centogene NV's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2023 was $0.00 Mil. It means Centogene NV's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Jun. 2023 .

Centogene NV's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2022 was $-5.23 Mil. It means Centogene NV's Accounts Payable & Accrued Expense declined by $5.23 Mil from Dec. 2021 to Dec. 2022 .

Centogene NV Change In Payables And Accrued Expense Historical Data

The historical data trend for Centogene NV's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centogene NV Change In Payables And Accrued Expense Chart

Centogene NV Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.16

3.47

29.19

-23.15

-5.23

Centogene NV Quarterly Data
	Dec17	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															2.76	-5.90	-1.21	-	-

Centogene NV Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.10 Mil.

Centogene NV Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Centogene NV's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Centogene NV (Centogene NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Centogene NV (NAS:CNTG) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

39K:Germany

Address

Am Strande 7, Rostock, MV, DEU, 18055

Website

https://www.centogene.com

Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.